Dr Geoff Brooke has 30 years of international experience as the founder, lead investor, chair/director of numerous healthcare companies with a realised value of more than $1.5 billion.
Most notably, he was managing director and founder of leading life sciences venture capital firm GBS Ventures, one of Asia Pacific’s premier investors in the healthcare space, where Dr Brooke was responsible for its healthcare venture activity in the region and raised $450 million in venture and private equity funds, focused on biopharmaceuticals, medical devices and services. He was also responsible for numerous investments and exits via NASDAQ and ASX public listings and trade sales, as well as being lead investor in numerous investments syndicated in multiple rounds with premier US venture firms. Dr Brooke was also president and founder of US-based seed healthcare venture capital firm, Medvest Inc, with investors including the venture capital arm of leading global multinational medical devices, pharmaceutical and consumer packaged goods manufacturer, Johnson & Johnson. Medvest was focused on founding companies based upon health care-related technology, including pharmaceuticals, biotechnology, therapeutic devices, medical services and information systems.
Dr Brooke now acts a private investor in, and independent director for, a number of small to medium-sized Australian and US private and public companies, including as non-executive director for ASX-listed Acrux.
Dr Brooke holds a Bachelor of Medicine and a Bachelor of Surgery from Melbourne University, and a Masters of Business Administration from IMEDE Switzerland (now IMD).
